Next 10 |
home / stock / iccm / iccm articles
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Tuesday. The Dow traded up 0.27% to 35,4...
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million publ...
IceCure Medical Ltd. (NASDAQ: ICCM) shares are trading higher Tuesday after an independent study concluded that the company's IceCure system of...
Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently a...
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling more than 150 points on Monday. The Dow traded down 0.49% to ...
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives ...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 40 points on Monday. The Dow traded down 0.60% to 33,306....
IceCure Medical Ltd (NASDAQ: ICCM) announced that new data was presented at the European Society of Breast Imaging Scientific Meeting, validat...
U.S. stocks traded mixed this morning, with the Dow Jones falling around 100 points on Monday. Following the market opening Monday, the Dow traded ...
News, Short Squeeze, Breakout and More Instantly...
IceCure Medical Ltd. Company Name:
ICCM Stock Symbol:
NASDAQ Market:
2024-04-15 10:06:29 ET DENVER, Colo., Apr 15, 2024 ( 247marketnews.com )- IceCure Medical Ltd. (NASDAQ: ICCM ) stated that it submitted final data to the U.S. Food and Drug Administration (“FDA”) requesting marketing authorization for ProSense, which received the FDA...
IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing Authorization to Treat Early-Stage Breast Cancer PR Newswire Data presentation ...
IceCure Medical Reports Full Year 2023 Financial Results: Global ProSense® and Disposables Sales Increase 26% as Company Continues Transition to Commercial Phase and Expects to Submit ICE3 Breast Cancer Study Data to FDA this Month for Marketing Clearance PR Newswire Co...